Showing results (351-360 of 6,497) with videos related to
Sort By:
Pageof 650
Human Vaccines & Immunotherapeutics|November 21, 2019
Vaccination coverage and its determinants of live attenuated hepatitis A vaccine among children aged 24-59 months in 20 rural counties of 10 provinces of China in 2016Xiaoli Liu, Chenlu Yang, Xueqi Qu, et al.Human Vaccines & Immunotherapeutics|October 31, 2019
Trends in human papillomavirus (HPV) vaccination initiation among adolescents aged 13-17 by metropolitan statistical area (MSA) status, National Immunization Survey - Teen, 2013 - 2017Tanja Y Walker, Laurie D Elam-Evans, Charnetta L Williams, et al.Human Vaccines & Immunotherapeutics|November 1, 2019
Recombinant BCG expressing the LTAK63 adjuvant induces increased early and long-term immune responses against MycobacteriaCarina Carvalho Dos Santos, Dunia Rodriguez, Alex Kanno Issamu, et al.Human Vaccines & Immunotherapeutics|November 28, 2017
A comprehensive analysis of Italian web pages mentioning squalene-based influenza vaccine adjuvants reveals a high prevalence of misinformationDonatella Panatto, Daniela Amicizia, Lucia Arata, et al.Human Vaccines & Immunotherapeutics|November 30, 2017
Production of a germline-humanized cetuximab scFv and evaluation of its activity in recognizing EGFR- overexpressing cancer cellsArsham Banisadr, Yaghoub Safdari, Anvarsadat Kianmehr, et al.Human Vaccines & Immunotherapeutics|December 21, 2017
Effectiveness and practical uses of 23-valent pneumococcal polysaccharide vaccine in healthy and special populationsYang Wang, Jingxin Li, Yuxiao Wang, et al.Human Vaccines & Immunotherapeutics|December 13, 2017
Revisiting knowledge, attitudes and practice (KAP) on human papillomavirus (HPV) vaccination among female university students in Hong KongJonathan Tin Chi Leung, Chi-Kin LawHuman Vaccines & Immunotherapeutics|December 2, 2017
Public policy for meningococcal vaccinationJ Claire CameronHuman Vaccines & Immunotherapeutics|December 6, 2017
Assessment of the ability of V920 recombinant vesicular stomatitis-Zaire ebolavirus vaccine to replicate in relevant arthropod cell cultures and vector speciesNicholas A Bergren, Megan R Miller, Thomas P Monath, et al.Human Vaccines & Immunotherapeutics|February 7, 2019
Immunogenicity and safety of the new MMR vaccine containing measles AIK-C, rubella Takahashi, and mumps RIT4385 strains in Japanese children: a randomized phase I/II clinical trialTetsuo Nakayama, Masahiro Eda, Motonori Hirano, et al.Pageof 650